|
PHF13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.284200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.080200E-01 |
| Normal-vs-Stage2 |
2.740400E-01 |
| Normal-vs-Stage3 |
1.770230E-01 |
| Normal-vs-Stage4 |
7.550400E-01 |
| Stage1-vs-Stage2 |
1.782400E-01 |
| Stage1-vs-Stage3 |
5.405800E-02 |
| Stage1-vs-Stage4 |
5.815800E-01 |
| Stage2-vs-Stage3 |
9.054200E-01 |
| Stage2-vs-Stage4 |
4.337800E-01 |
| Stage3-vs-Stage4 |
3.517200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.477800E-01 |
| Normal-vs-AfricanAmerican |
3.942200E-02 |
| Normal-vs-Asian |
9.289000E-01 |
| Caucasian-vs-AfricanAmerican |
4.959500E-03 |
| Caucasian-vs-Asian |
8.005000E-01 |
| AfricanAmerican-vs-Asian |
3.564400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.271600E-01 |
| Normal-vs-Female |
3.267800E-01 |
| Male-vs-Female |
5.558600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.221600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.751200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.672800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.118600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.629800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.635800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.894200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.854600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.570600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.220000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.658200E-02 |
| Normal-vs-Grade 2 |
7.484600E-01 |
| Normal-vs-Grade 3 |
1.193970E-01 |
| Normal-vs-Grade 4 |
6.739400E-01 |
| Grade 1-vs-Grade 2 |
4.232200E-02 |
| Grade 1-vs-Grade 3 |
1.506040E-02 |
| Grade 1-vs-Grade 4 |
2.871900E-02 |
| Grade 2-vs-Grade 3 |
1.461500E-02 |
| Grade 2-vs-Grade 4 |
4.606400E-01 |
| Grade 3-vs-Grade 4 |
2.854200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.270400E-01 |
| Normal-vs-ccB subtype |
4.428200E-02 |
| ccA subtype-vs-ccB subtype |
2.518700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.766990E-01 |
| Normal-vs-N1 |
5.935000E-01 |
| N0-vs-N1 |
8.493200E-01 |
|
|
